Applications
News & Events
Latest News
02/06/2023 Advanced Electrophoresis Solutions Ltd. is pleased to announce their agreement with MEDISPEC as the exclusive distributor of its products in India. Under the agreement MEDISPEC will also become the provider of service and application support in the covered regions. Read More>>
12/22/2022 Advanced Electrophoresis Solutions Ltd. recieves ISO 9001:2015 certificate of registration for the quality management system of the manufacture of instruments, ampholytes and supplies for icIEF.
12/02/2022 Government of Canada boosts economic growth of three Waterloo Region tech businesses to fuel job creation
Advanced Electrophoresis Solutions Ltd. is a Cambridge-based medical technology manufacturer that specializes in developing test instruments for pharmaceutical companies to analyze protein structures and interactions… Read More>>
06/21/2022 Canadian High-tech Advanced Electrophoresis Solutions Ltd. Secured GCI-led Investment to Expand its Business in Biopharma Industry Read More>>
Events
We are excited to announce that our AES team will be present at WCBP 2024, taking place from January 23-25th, 2024, in Washington D.C!
At Booth #8, we will be showcasing two informative posters that highlight our latest innovations and the performance of our products in CMC strategy and drug development. We invite you to join us and explore:
Our CEInfinite icIEF platforms are ideal for CMC and QC operations. Discover how they can seamlessly integrate into your existing methods, offering a potential alternative without necessitating significant changes.
Our range of high-performance critical reagents is designed for superior icIEF. These solutions are tailored to support your CMC strategy and facilitate the entire drug development lifecycle.
We look forward to the opportunity to discuss our offerings and how they can benefit your projects. See you at WCBP 2024!
Stay tuned for more information about upcoming webinars and conferences.
About the Company
Advanced Electrophoresis Solutions Ltd. (AES) was founded in 2010. The Company is dedicated in providing cutting-edge instrumentations, ampholytes, and supplies in the icIEF field. The Company now has become a unique total solution provider for protein icIEF separation and characterization in the industry. The Company has been working with leading biopharmaceutical companies and research institutes to address their diversely urgent needs and save millions of dollars to meet their budget goal by avoiding potential product disruption, establishing QC methods, and helping regulatory filing.
Our Mission
Accelerate your biologics development,
protein characterization and save your budget.
Managing Team
Tiemin Huang, Ph.D.
President and CEO
Victor Li, M.Sc. COO
Tong Chen, Ph.D. CCO
Tao Bo, Ph.D. CMO
Matt Courtney, Ph.D. CSO
Our Advisors
Gerard Rozing, Ph.D.
Scientific Advisor
Dr. Rozing is a pioneer in high-performance liquid chromatography (HPLC) technology and has worked in the industry for over 30 years. He has been widely recognized by the separation science community as an outstanding researcher for his ability to bridge fundamental science with technical solutions in an industrial environment. Dr. Rozing has authored 57 well-cited publications, mainly in the separation sciences, and holds six U.S. patents.
As a Scientific Advisor of AES, Dr. Xing-Zheng Wu has been involved in capillary electrophoresis (CE) research since 1992. He is the first author of the paper (Electrophoresis, 16, 1474-1478 (1995)), which described the first icIEF cartridge with membrane technology that allows continuous sample injection and analysis. He published over 80 original works in the fields of in-capillary pre-concentration for CE separation and detection of low concentration samples. In addition to CE, his research interests include optical beam deflection method, fluorescence, chemiluminescence, and nano-particles. Dr. Wu is a Professor of Fukuoka Institute of Technology in Japan. He holds a Ph.D. in Analytical Chemistry from the University of Tokyo.
Xing-Zeng Wu, Ph.D.
Scientific Advisor
Dr. Jinjun Shan
Scientific Advisor
Dr. Jinjun Shan is an internationally recognized expert in the areas of dynamics and control of mechatronics systems, particularly on modeling and control of piezoelectric actuators and their industrial applications. As a Scientific Advisor of AES, Dr. Shan has been working on the development of miniature high-precision autosampler for automatic capillary electrophoresis (CE) injection control for CEInfinite icIEF since 2014. He is currently a Full Professor at York University and the chair of the Department of Earth and Space Science Engineering. Dr. Shan received his Ph.D. degree from Harbin Institute of Technology, China, in 2002. His research progress is demonstrated through over 180 peer-reviewed journal and conference publications and 2 issued patents. Dr. Shan is a Fellow of the Engineering Institute of Canada (EIC), an Associate Fellow of AIAA, an Alexander von Humboldt Fellow and JSPS Fellow.
Our Partners
Our Customers
are global leading pharmaceutical
companies and universities, including
BMS, Regeneron,
Alexion, Eli Lilly,
Takeda, Amgen,
Novo Nordisk,
Boehringer Ingelheim,
Biogen, Novartis, etc
York University
University of Waterloo
University of Salzburg
VU University Amsterdam
Aalen University
Stanford University, etc
Contact
Address: 380 Jamieson Parkway, Unit 7 and 8,
Cambridge, ON, N3C 4N4 Canada
Phone: +1 (519) 653-6888 / +1 (519) 804-4200
Fax: +1 (519) 804-4288
Email: info@aeslifesciences.com
